Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-045513
Filing Date
2013-08-19
Accepted
2013-08-19 16:26:30
Documents
1
Period of Report
2013-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd388708.html 4  
1 FORM 4 rrd388708.xml 4 3085
  Complete submission text file 0001181431-13-045513.txt   4589
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2501 AERIAL CENTER PARKWAY SUITE 205 MORRISVILLE NC 27560
Business Address
D'Alonzo Thomas (Reporting) CIK: 0001382542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 131048539